rs1557110499
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_001256789.3(CACNA1F):βc.952_954delβ(p.Phe318del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,593 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: not found (cov: 24)
Exomes π: 9.1e-7 ( 0 hom. 1 hem. )
Consequence
CACNA1F
NM_001256789.3 inframe_deletion
NM_001256789.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.41
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_001256789.3. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant X-49228310-CGAA-C is Pathogenic according to our data. Variant chrX-49228310-CGAA-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 438129.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49228310-CGAA-C is described in Lovd as [Pathogenic]. Variant chrX-49228310-CGAA-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1F | NM_001256789.3 | c.952_954del | p.Phe318del | inframe_deletion | 7/48 | ENST00000323022.10 | NP_001243718.1 | |
CACNA1F | NM_001256790.3 | c.757_759del | p.Phe253del | inframe_deletion | 7/48 | NP_001243719.1 | ||
CACNA1F | NM_005183.4 | c.952_954del | p.Phe318del | inframe_deletion | 7/48 | NP_005174.2 | ||
CACNA1F | XM_011543983.3 | c.757_759del | p.Phe253del | inframe_deletion | 7/47 | XP_011542285.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1F | ENST00000323022.10 | c.952_954del | p.Phe318del | inframe_deletion | 7/48 | 1 | NM_001256789.3 | ENSP00000321618 | ||
CACNA1F | ENST00000376251.5 | c.757_759del | p.Phe253del | inframe_deletion | 7/48 | 1 | ENSP00000365427 | |||
CACNA1F | ENST00000376265.2 | c.952_954del | p.Phe318del | inframe_deletion | 7/48 | 1 | ENSP00000365441 | P1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097593Hom.: 0 AF XY: 0.00000276 AC XY: 1AN XY: 362963
GnomAD4 exome
AF:
AC:
1
AN:
1097593
Hom.:
AF XY:
AC XY:
1
AN XY:
362963
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2022 | This variant, c.952_954del, results in the deletion of 1 amino acid(s) of the CACNA1F protein (p.Phe318del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 438129). This variant has been observed in individuals with congenital stationary night blindness (PMID: 11281458, 23714322, 30825406; Invitae). It has also been observed to segregate with disease in related individuals. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 15, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23714322, 11281458, 32581362, 30825406) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | CACNA1F: PM2, PS4:Moderate, PM3:Supporting, PM4:Supporting - |
Cone-rod dystrophy Pathogenic:1
Pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Congenital stationary night blindness Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at